U.S. Physical Therapy, Inc. (USPH)

Official site

HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

$99.72

+2.52 (+2.59%)

Market Cap: $1.45B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

65%(26/40)

Avg Surprise

+9.72%

Streak

1 Q

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$0.82

Range$0.63 - $1.11

5 analysts

Revenue Consensus

$221M

Range$215M - $224M

7 analysts

Last 12 of 40 reported quarters and 1 upcoming estimate

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.82	$0.63 - $1.11	-	-	5	-	-
Sep 30, 2026Sep 26 Reported Nov 4, 2026Reported Nov 4	$0.80	$0.76	$0.57 - $0.90	+5.26%	Beat	6	1 1 30d	+21.2%
Jun 30, 2026Jun 26 Reported Aug 5, 2026Reported Aug 5	$0.75	$0.85	$0.78 - $0.91	-11.76%	Miss	5	No revisions (30d)	-7.4%
Mar 31, 2026Mar 26 Reported May 6, 2026Reported May 6	$0.46	$0.52	$0.35 - $0.64	-11.54%	Miss	7	No revisions (30d)	-4.2%
Dec 31, 2025Dec 25 Reported Feb 25, 2026Reported Feb 25	$0.67	$0.67	$0.61 - $0.73	-0.56%	Miss	6	1 0 30d	+31.4%
Sep 30, 2025Sep 25 Reported Nov 5, 2025Reported Nov 5	$0.66	$0.67	$0.59 - $0.73	-1.49%	Miss	5	3 1 30d	-4.3%
Jun 30, 2025Jun 25 Reported Aug 6, 2025Reported Aug 6	$0.81	$0.69	$0.62 - $0.78	+17.39%	Beat	5	0 6 30d	+11.0%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$0.48	$0.45	$0.34 - $0.63	+6.67%	Beat	6	0 4 30d	-5.9%
Dec 31, 2024Dec 24 Reported Feb 26, 2025Reported Feb 26	$0.51	$0.70	$0.56 - $0.77	-26.78%	Miss	7	2 3 30d	-13.6%
Sep 30, 2024Sep 24 Reported Nov 5, 2024Reported Nov 5	$0.69	$0.68	$0.61 - $0.73	+1.47%	Beat	6	No revisions (30d)	+11.3%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$0.73	$0.82	$0.74 - $0.89	-10.98%	Miss	6	No revisions (30d)	-3.9%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$0.51	$0.56	$0.46 - $0.67	-8.93%	Miss	6	No revisions (30d)	-13.6%
Dec 31, 2023Dec 23 Reported Feb 28, 2024Reported Feb 28	$0.59	$0.57	$0.48 - $0.66	+3.51%	Beat	6	No revisions (30d)	+1.7%

Dividends

Next ex-dividend: Nov 16, 2026

Dividend Metrics

Forward Yield1.85%

Forward Annual Dividend$1.84

Payout Ratio30.75%

FrequencyQuarterly

Pay MonthsApr, Jun, Sep, Dec

Growth

3Y CAGR+3.15%

5Y CAGR+41.26%

USPH dividend history and ex-dividend dates Run USPH in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	37.21	EV/EBITDA	16.99x
Price/FCF	21.54x	FCF Yield	4.64%
Profitability
Profit Margin	4.01%	Operating Margin	11.10%
ROE	6.51%	ROIC	8.54%
Financial Health
Debt/Equity	0.57x	Interest Coverage	6.35x
Current Ratio	1.42x	Quick Ratio	1.42x
Trading Statistics
Beta	1.13	Avg Volume	180.60K
52-Week High	$100.98	52-Week Low	$57.42

Technical Indicators Dashboard

Moving Averages

SMA 10$88.94

SMA 20$87.59

SMA 50$84.13

SMA 200$76.34

EMA 10$90.51

EMA 20$88.24

EMA 50$84.62

EMA 200$78.36

MACD

Line: 2.52Signal: 1.48Hist: 1.04

ADX

ADX: 21.0+DI: 35.4-DI: 14.4

Aroon & PSAR

Aroon Up100.0

Aroon Down52.0

PSAR$83.95

Bollinger Bands

Upper Band$95.62

Lower Band$79.56

%B Position1834%(Upper)

Band Width1.25

RSI (14-Day)

Overbought

76.9

Momentum Oscillators

Stoch %K89.2

Stoch %D75.8

Williams %R-6.8

ROC (10d)12.6%

Momentum11.19

CCI (20d)309.2

MFI (14d)60.7

Volatility Measures

ATR (14d)$3.54(3.5%)

StdDev (20d)4.02

Hist Vol43.6%(High)

Volume Flow

VWAP$99.05

OBV2.3M

AD Line-31.7M

CMF (20d)-0.016

Volume Metrics

Avg Vol (20d)182.6K

Vol Ratio1.6x(High)

VWMA (20d)$88.30

Pivot Points

R3$107.77

R2$104.37

R1$100.79

Pivot Point$97.39

S1$93.81

S2$90.41

S3$86.83

Advanced Oscillators

TSI28.10

Ultimate Osc61.1

KST63.76

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$222.56M	$214.06M	$198.29M	$202.73M	$197.13M	$197.34M	$183.79M	$180.45M	$168.03M	$167.19M	$155.68M	$154.80M
Cost of Revenue	$132.32M	$127.52M	$121.49M	$121.97M	$118.69M	$115.78M	$113.10M	$111.34M	$101.56M	$98.05M	$95.36M	$92.20M
Gross Profit	$90.23M	$86.53M	$76.79M	$80.76M	$78.44M	$81.56M	$70.69M	$69.11M	$66.48M	$69.14M	$60.32M	$62.60M

Operating Expenses	$65.03M	$64.59M	$64.31M	$63.99M	$58.98M	$56.62M	$51.05M	$49.45M	$53.63M	$53.57M	$45.39M	$65.06M
R&D	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
SG&A	$17.83M	$19.00M	$18.27M	$18.13M	$17.41M	$17.48M	$16.25M	$15.57M	$14.38M	$14.25M	$14.09M	$13.90M
Operating Income	$25.10M	$21.95M	$12.48M	$16.77M	$25.33M	$24.94M	$19.64M	$19.65M	$12.85M	$15.57M	$14.93M	$-2,430,000

Interest Income	$370,000	$437,000	$379,000	$342,000	$394,000	$429,000	$417,000	$570,000	$1.25M	$1.32M	$1.81M	$1.67M
Interest Expense	$3.58M	$3.34M	$2.79M	$2.35M	$2.41M	$2.42M	$2.28M	$2.05M	$2.02M	$1.98M	$1.97M	$2.01M
Income Before Tax	$21.56M	$19.05M	$10.56M	$14.96M	$22.88M	$22.65M	$17.33M	$18.32M	$12.34M	$14.79M	$14.76M	$106,000
Income Tax Expense	$3.97M	$4.16M	$2.41M	$5.78M	$5.23M	$4.93M	$3.86M	$5.83M	$2.56M	$3.08M	$3.14M	$1.40M

Net Income	$17.59M	$14.90M	$8.16M	$9.18M	$17.64M	$17.72M	$13.47M	$12.49M	$9.78M	$11.71M	$11.62M	$-1,293,000

EBITDA	$31.05M	$28.00M	$19.08M	$21.71M	$36.70M	$30.81M	$25.16M	$25.59M	$17.60M	$20.07M	$19.11M	$4.66M
EBIT	$24.67M	$21.95M	$12.97M	$16.96M	$30.76M	$24.65M	$19.19M	$19.80M	$13.11M	$15.45M	$14.91M	$446,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about USPH

News

US Physical Therapy Q3FY26 Results: Revenue up 13%, EBITDA grows 16%

US Physical Therapy reported a 13% increase in total revenue to $223 million for Q3 FY26, driven by 8% volume growth and higher reimbursement rates from new hospital partnerships. EBITDA grew by 16% to $28 million...

scanx.trade•Nov 5, 2026 6:57 PM ET11/5/26•Bullish

USPH: Hospital affiliations and stronger PT volume drove double-digit Q3 growth; FY EBITDA guidance held

U.S. Physical Therapy, Inc. (USPH) reported strong Q3 2026 results with revenue growing 13% and EBITDA rising over 16%...

TradingView•Nov 5, 2026 1:10 PM ET11/5/26•Bullish

US Physical Therapy Inc (USPH) (Q3 2026) Earnings Call Highlights: Record Visits and Revenue ...

US Physical Therapy Inc (USPH) reported record patient visits for 27 consecutive months and a 13% increase in total revenue to $223 million in Q3 2026. The company achieved a record net rate per visit of $112...

Yahoo! Finance Canada•Nov 5, 2026 12:25 PM ET11/5/26•Somewhat-Bullish

US Physical Therapy Q3 2026 Earnings Call Transcript

US Physical Therapy reported a 13% increase in Q3 2026 total revenue, driven by an 8% growth in physical therapy visits and higher reimbursement rates from hospital affiliations. EBITDA grew over 16%...

Benzinga•Nov 5, 2026 12:10 PM ET11/5/26•Bullish

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

U.S. Physical Therapy (NYSE:USPH) reported strong Q3 2026 results, with revenue up 12.9% year-on-year to $222.6 million...

TradingView•Nov 4, 2026 5:13 PM ET11/4/26•Bullish

USPH Valuation and Fair Value

P/E: 37.2x
Forward P/E: 29.2x
EV/EBITDA: 17.0x
P/FCF: 21.5x
PEG: 2.9x
P/B: 3.5x

See GNG's fair value

USPH Profitability: Margins, ROIC and FCF

Gross margin: 39.9%
Operating margin: 11.1%
Net margin: 4.0%
ROIC: 8.5%
ROE: 6.5%
FCF margin: 8.2%
FCF yield: 4.6%

USPH Competitors

Company	Ticker
Pacira BioSciences, Inc.	PCRX
Phibro Animal Health Corporation	PAHC
Immunocore Holdings Ltd	IMCR
UroGen Pharma Ltd	URGN
Nuvation Bio Inc	NUVB
Enovis Corp	ENOV
Uniqure NV	QURE
Rapport Therapeutics, Inc. Common Stock	RAPP

Sector: Healthcare

USPH Analyst Ratings

Consensus: Buy
Analysts: 7
Strong Buy: 4
Buy: 2
Hold: 1
Sell: 0
Strong Sell: 0

USPH Bull Case vs Bear Case

Bull case

85.7% of USPH's analyst ratings are Buy or Strong Buy.

Bear case

USPH beat EPS estimates in 37.5% of its last 8 reported quarters.

USPH Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -2.9%
EPS estimate (fiscal period ending Dec 31, 2026): $0.82

USPH Dividend

Forward yield: 1.8%
Payout ratio: 30.8%
3Y DPS growth: 3.2%
5Y DPS growth: 41.3%
Pay months: Apr, Jun, Sep, Dec

USPH dividend history

USPH Earnings Date

USPH reports Feb 23, 2027, after the close. The date is estimated.

USPH Earnings Call

The latest USPH earnings call transcript on file is labeled 2026Q3.

Read the 2026Q3 transcript

USPH ETF Holders

GNG tracks 8 ETFs that hold USPH. The largest weights:

iShares Core S&P Small-Cap ETF (IJR), 0.07% of the fund
iShares Russell 2000 ETF (IWM), 0.04% of the fund
Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.04% of the fund
Dimensional U.S. Core Equity 2 ETF (DFAC), 0.02% of the fund
Vanguard Health Care Index Fund ETF Shares (VHT), 0.02% of the fund

Open the ETF Stock Exposure tool for USPH

See insider activity

Frequently Asked Questions About USPH

When is USPH's next ex-dividend date?

USPH's next ex-dividend date is Nov 16, 2026, for a declared dividend of $0.46 per share (record date Nov 16, 2026, payable Dec 11, 2026).

When does USPH report earnings?

U.S. Physical Therapy, Inc. (USPH) is expected to report earnings on Feb 23, 2027.

What is USPH's current dividend yield?

U.S. Physical Therapy, Inc. (USPH) has a forward dividend yield of 1.85%.

Does USPH pay dividends?

Yes, U.S. Physical Therapy, Inc. pays dividends with a forward dividend yield of 1.85%.

What is USPH's P/E ratio?

U.S. Physical Therapy, Inc. has a price-to-earnings (P/E) ratio of 37.21.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In